Navigation Links
Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
Date:4/22/2013

WARSAW, Indiana, April 22, 2013 /PRNewswire/ --

Located in Warsaw Indiana, OrthoTec is a major conference and exhibition for orthopaedic device manufacturers. Now open for public registration for conference program and dedicated workshops

In addition to a slate of industry leaders joining the speaking faculty for 2013, the OrthoTec Conference and Exhibition this year is featuring two special half-day workshops on June 4, 2013. These workshops are must-attend training sessions for design, R&D and quality professionals at orthopaedic manufacturers looking to learn the latest methods in risk management and material selection - two essential processes in medical device development. For more information about the event and its featured workshops, visit http://www.orthotecshow.com

Workshop 1: Application of Risk Management throughout the Product Lifecycle

June 4, 2013 from 9:00AM - 12:00PM (Grace College in Warsaw, IN)

This 3-hour workshop covers all the basics of risk management in medical device development and throughout the product lifecycle, including the integration of risk management into the quality system as a whole.  The workshop will cover several of the tools utilized in an effective risk management system and provide real-life examples of risk assessment.   This is an interactive workshop giving you the opportunity to experience firsthand the considerations and challenges associated with identifying, evaluating, and mitigating risks so you can become an expert in risk management at your company!

  • Part 1: Basic Risk Considerations
  • Part 2: Using Risk Management Tools
  • Part 3: Interactive Case Studies

Click here to find out more

Workshop 2: Establishing a Robust Materials Selection Process

June 4, 2013 from 1:00PM - 4:00PM (Grace College in Warsaw, IN)

This 3-hour workshop covers all the basics of material selection from both a tactical and strategic perspective. Design and regulatory considerations will be discussed during the workshop with an emphasis on feasibility and required testing as well as associated costs and timeframes. The workshop will cover the resources available to assist with material selection and provide examples of utilizing a risk based approach for determining which material would be best for a device and its intended use. This is an interactive workshop giving you the opportunity to experience firsthand the considerations and challenges associated with material selection.

  • Part 1: Overview of ISO 10993 & ASM Database
  • Part 2: Materials Selection Considerations
  • Part 3: Interactive Case Studies

Click here to find out more

Both workshops will be led by Scott Durlacher , Director of Compliance and his team at Anson Group.  Mr. Durlacher has over 18 years of diverse industry and consulting experience, including leadership positions in regulatory affairs, quality assurance, research and development, and operations in medical device, biotech, and biologics organizations.  To view Mr. Durlacher's biography, click here.

The OrthoTec Conference and Exhibition is the annual industry gathering for orthopaedic technologists and business leaders at the "Orthopaedic Capital of the World" - Warsaw, Indiana. The 2013 conference program features a truly thought-leading presenter line-up and influential decision-makers from FDA/CDRH, Stryker, Medtronic Spine, Biomet, Zimmer, Depuy Synthes, OrthoSensor, Orthogen, Cook BioTech, Case Western Reserve University, GHX, MED Institute and others.

To learn more about the conference program and the 2013 speaker line-up, visit http://www.orthotecshow.com 

The OrthoTec Conference and Exhibition is well-attended annually by colleagues from Biomet, DePuy Synthes, Zimmer, Medtronic Spinal & Biologics, Stryker, Tornier, OrthoPediatrics, Symmetry Medical, Paragon Medical, and more.  See here for a full list of attending companies. Qualified professionals will receive complimentary admission to the event. OrthoTec 2013 is sponsored by Solvay Plastics.

About UBM Canon-Organizer of OrthoTec

UBM Canon LLC, the leading B2B media company dedicated exclusively to the global $3 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.

Sponsorship Opportunities:
sponsorship@ubm.com  
+1-310-996-9435


Conference Program:
Vu Nguyen
+1-310-996-9495
Vu.Nguyen@ubm.com


Marketing Contact:
Kelly Ryan
+1-310-445-8516
Kelly.Ryan@ubm.com


'/>"/>
SOURCE UBM Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. CMC Biologics Highlights Technical Acumen at Upcoming Conferences
2. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
3. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Titles Until the End of December at Chemical Publishing Company
4. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
5. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
6. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
7. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
8. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
9. American Management Association Teams With Biogen Idec To Create Life Skills Workshops For People Living With Hemophilia
10. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
11. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... February 27, 2017 Four US ... evaluation today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ... California Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... ETF Trends, market observers are growing more bullish on ... enact reforms to free cash held overseas for tax ...
(Date:2/26/2017)... ... ... Rob Lowe is a well recognized television personality, so it seems natural he would ... important to the American public and important to society at large. An upcoming episode ... the world for a few years. , The climate and how we relate to ...
(Date:2/24/2017)... KNOXVILLE, Tenn. , Feb. 24, 2017 /PRNewswire/ ... ) ("Provectus" or the "Company"), a clinical-stage oncology ... information regarding the deadline to participate in its ... million units, consisting of shares of common stock ... stockholders and holders of listed warrants. ...
(Date:2/24/2017)... Staten Island, NY (PRWEB) , ... February 24, 2017 , ... ... exponential rate. Founded in late 2014, FireflySci had the goal of bringing their ... 2017, that goal continues to shape the path that FireflySci is going on as ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
Breaking Biology News(10 mins):